生物补片与/或小针距预防疝的多专科2×2析因随机对照试验
该2×2析因随机对照试验在高危患者(超重/肥胖、吸烟)中比较了预防性生物补片与无补片、小针距(0.5×0.5cm)与大针距(1×1cm)筋膜关闭对术后1年主要并发症的影响。共随机107例患者,结果显示生物补片与小针距均无显著获益,主要并发症发生率组间无差异。
要点
- 在高危患者中,预防性生物补片未降低术后1年主要并发症。
- 小针距筋膜关闭较大针距未降低术后1年主要并发症。
- 生物补片和小针距均无获益,暂不建议广泛采用。
核心结论
- 在高危患者中,预防性生物补片和小针距筋膜关闭对术后1年主要并发症均无获益。
研究设计与样本
- 多专科2×2析因随机对照试验,纳入高危患者(超重/肥胖、当前吸烟)行中线切口(≥5cm)腹部手术,随机分为生物补片或无补片、小针距(0.5×0.5cm)或大针距(1×1cm)筋膜关闭。
- 共随机107例:补片组52例(49%),无补片组55例(51%);小针距组55例(51%),大针距组52例(49%)。
- 主要结局为术后1年主要并发症(腹壁切口疝、手术部位感染、再手术、死亡)。
主要发现
- 术后1年主要并发症补片组与无补片组分别为21%与16%(p=0.62),小针距组与大针距组分别为18%与19%(p=1.00)。
临床怎么用
- 在高危患者中,不应常规采用预防性生物补片或小针距筋膜关闭来预防术后主要并发症。
局限性
- 样本量较小(107例),可能不足以检测较小差异。
- 随访仅1年,长期效果未知。
- 结果仅适用于所定义的高危人群,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ventral incisional hernias are the most common complication after abdominal operation. Randomized trials have shown efficacy of prophylactic synthetic mesh and small bites. Adoption of these practices has been limited due to concerns with placement of synthetic mesh in contaminated cases and small bites in an overweight population. We sought to assess the efficacy of prophylactic biologic mesh and small bites to prevent postoperative major complications: ventral incisional hernias, surgical site infection, reoperation, and death. STUDY DESIGN: High-risk patients (overweight/obese, current smoker) undergoing abdominal operation with a midline incision (5 cm or greater) were randomized (2 × 2 factorial trial) to receive either sublay biologic mesh or no mesh and either small bites (0.5 × 0. 5cm) or large bites (1 × 1 cm) fascial closure. The primary outcome measure was major complications at 1 year postoperative. CONSORT guidelines were followed, and this study was registered on clinicaltrials.gov (NCT03148496). Assuming α = 0.05, β = 0.20, and Δ = 20%, it was estimated that 105 patients were needed. Primary outcome was assessed using Fisher's exact test. RESULTS: A total of 107 patients were randomized: 52 (49%) to mesh, 55 (51%) to no mesh, 55 (51%) to small bites, and 52 (49%) to large bites. Of the patients, 16% were smokers, 31% were overweight, and 55% were obese. At 1 year postoperative, there were no differences in major complications between groups (mesh vs no mesh 21% vs 16%, p = 0.62; small vs large bites 18% vs 19%, p = 1.00). CONCLUSIONS: In this trial, biologic mesh and small bites appear to have no benefit. Further randomized trials are needed among high-risk patients before widespread adoption of prophylactic biologic mesh or small bites.
引用
- Coelho R, Dhanani NH, Lyons NB, et al. Hernia Prevention Using Biologic Mesh and/or Small Bites: A Multispecialty 2 × 2 Factorial Randomized Controlled Trial. J Am Coll Surg. 2023. PMID: 37458369. doi:10.1097/XCS.0000000000000705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。